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The basement membrane (BM) is a form of extracellular
matrix that underlies cell layers in nearly all animal tissues. Type
IV collagen, a major constituent of BMs, is critical for tissue
development and architecture. The enzyme peroxidasin (Pxdn),
an extracellular matrix-associated protein, catalyzes the formation of structurally reinforcing sulfilimine cross-links within the
collagen IV network, an event essential to basement membrane
integrity. Although the catalytic function of Pxdn is known, the
regulation of its activity remains unclear. In this work we show
through N-terminal sequencing, pharmacologic studies, and
mutational analysis that proprotein convertases (PCs) proteolytically process human Pxdn at Arg-1336, a location relatively
close to its C terminus. PC processing enhances the enzymatic
activity of Pxdn and facilitates the formation of sulfilimine
cross-links in collagen IV. Thus, PC processing of Pxdn is a key
regulatory step that contributes to its function and, therefore,
supports BM integrity and homeostasis.

The basement membrane (BM)2 is a form of extracellular
matrix (ECM) that provides structural support for nearly all
animal tissues. BMs also help to provide extracellular cues for
cellular adhesion, proliferation, migration, and differentiation
(1). Type IV collagen is a critical constituent of basement membranes (2). Collagen IV ␣ chains form triple helical protomers
that self-assemble into a mesh-like network with end-to-end
C-terminal associations known as NC1 hexamers. Sulfilimine
(SAN) bonds between opposing methionine and lysine residues bridge the trimer-timer interface of the NC1 hexamer and
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thereby structurally reinforce the collagen IV network (3). The
enzyme peroxidasin (Pxdn), a basement membrane-associated
heme peroxidase, catalyzes the formation of sulfilimine crosslinks, a process critical for BM and tissue integrity (4). For
example, peroxidasin loss of function in Drosophila and
Caenorhabditis elegans compromises gut architecture and
leads to early lethality (4, 5). In addition to structural reinforcement, the sulfilimine cross-link also confers immune privilege
to the collagen IV auto-antigen in human Goodpasture’s disease, a devastating condition presenting as rapidly progressive
glomerulonephritis with or without pulmonary hemorrhage.
The formation of sulfilimine cross-links by peroxidasin may,
therefore, protect against the development of Goodpasture’s
disease (6).
Peroxidasin is a member of the animal heme peroxidase
superfamily along with myeloperoxidase (MPO), eosinophil
peroxidase, lactoperoxidase, and thyroid peroxidase (TPO) (7,
8). Peroxidases use hydrogen peroxide (H2O2) to oxidize halide
ions (X⫺ ⫽ I⫺, Br⫺, Cl⫺) and form hypohalous acids (HOX).
Pxdn preferentially generates HOBr as a reactive intermediate
to form sulfilimine cross-links in collagen IV, which represents
the first known function for the element bromine (4, 9). Given
its critical function in the synthesis of basement membranes, it
is no surprise that peroxidasin is found throughout the animal
kingdom, whereas other animal heme peroxidases are restricted to vertebrates (10, 11). In addition, unlike other members of the animal heme peroxidase family, Pxdn is a multidomain protein that contains a leucine-rich region followed by
four immunoglobulin-like domains, the catalytic peroxidase
domain, and a C terminal von Willebrand factor type C (vWFC)
domain (7, 12, 13). The non-catalytic domains are generally
thought to participate in protein-protein interactions. Recent
work from our group revealed that the N-terminal Ig and peroxidase domains are necessary for the formation of collagen IV
cross-links (10).
In this work we find that proprotein convertases (PCs) cleave
human peroxidasin (hPxdn) at Arg-1336 near its C terminus.
PC processing of Pxdn enhances HOBr production, which in
turn promotes the formation of sulfilimine cross-links in the
collagen IV network of basement membranes. Thus, PC processing represents a key regulatory event in Pxdn biosynthesis
and function.
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FIGURE 1. Heterologously expressed human peroxidasin is proteolyzed.
A, schematic depiction of recombinant hPxdn with leucine repeat-rich (LRR),
immunoglobulin (Ig), peroxidase, and vWFC domains. His6 and V5 epitope
tags were added to the C terminus. Validated intramolecular disulfide bridges
are shown as connected lines, while suggested intermolecular disulfides are
labeled S (8, 18). B, immunoblot of purified, recombinant hPxdn. C, immunoblot of ammonium sulfate-precipitated media under reducing conditions
from HEK293 cells stably transfected with Pxdn and cultured without
(control) or with indicated protease inhibitors. AEBSF (4-(2-aminoethyl)benzenesulfonyl fluoride) at 1 mM was cytotoxic. Blots were probed with
anti-V5 antibody and are representative of three independent experiments.

Results
hPXDN Is a Substrate for PC Processing—In our earlier work
(4) we attempted to affinity-purify recombinantly expressed
hPxdn using a C-terminal His6 tag (Fig. 1A). Unfortunately, an
⬃30-kDa protein predominated the affinity-purified product
instead of the predicted 170-kDa full-length Pxdn protein (Fig.
1B). We initially hypothesized that the protein may undergo
nonspecific proteolytic degradation at the C-terminal end,
creating a 30-kDa fragment that is captured by affinity chromatography. To test this hypothesis, we treated peroxidasin-expressing cells with several protease inhibitors to suppress proteolysis. None of these inhibitors resulted in the appearance of
the expected full-length product (Fig. 1C). Rather than nonspecific proteolysis, we then considered whether Pxdn may
undergo physiologic proteolytic processing during biosynthesis. Many secretory proteins are synthesized as inactive precursors that in addition to signal peptide cleavage undergo posttranslational processing to become biologically active (14). A
family of Ca2⫹-dependent subtilisin-like secretory serine proteases known as PCs are often responsible for this form of proteolytic processing (15). To explore this possibility, a PC site
prediction algorithm (ProP 1.0 Server) was used to determine
whether Pxdn possessed any potential PC sites that often consist of a core (K/R)Xn(K/R) sequence (X ⫽ any amino acid; n ⫽
0, 2, 4, or 6) (14, 16). A RGRR motif with predicted cleavage at
the C-terminal Arg-1336 was found immediately preceding the
vWFC domain, a location consistent with the observed 30-kDa
C-terminal fragment. To test whether PCs process Pxdn, we
treated Pxdn-expressing cells with a PC inhibitor, decanoyl-
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RVKR-chloromethyl ketone and found that these cells predominantly produce the expected full-length Pxdn product (Fig.
2B). To verify these findings, Pxdn-expressing cells were cotransfected with a protein PC inhibitor, ␣-1 antitrypsin Portland variant (PDX), and these cells also produced full-length
Pxdn (Fig. 2C) (17). Taken together, these data suggest that
Pxdn undergoes PC processing, which releases a 30-kDa C-terminal fragment.
PC processing of secreted proteins can occur intracellularly
often in the Golgi or extracellularly at the cell surface (16).
Immunoblotting of cell lysates revealed a predominance of fulllength Pxdn in contrast to the media fraction where the C-terminal 30-kDa fragment is in excess. These data suggest that PC
processing of Pxdn primarily occurs extracellularly (Fig. 2D).
In their discovery of Pxdn in Drosophila, Fessler and
co-workers (13) found that Pxdn is a disulfide-linked homotrimer and hypothesized that the vWFC domain may act as an
oligomerization domain. Recent work with hPxdn has confirmed these findings (8, 18). PC processing of hPxdn allowed us
to investigate the oligomerization status and disulfide linkage of
the vWFC domain, as these questions remained unexamined.
Under non-reducing conditions, the larger 150-kDa Pxdn fragment was replaced by a much slower migrating presumed
trimer band. However, the mobility of the C-terminal 30-kDa
fragment was unchanged, suggesting this fragment lacks intermolecular disulfide bridges (Fig. 3A). If the vWFC domain promotes homotrimerization, one might expect that the C-terminal vWFC fragment may itself be a non-covalent oligomer. Gel
filtration chromatography of the C-terminal fragment revealed
an apparent molecular mass of 146 kDa suggesting an oligomer,
although higher order than the predicted trimer (Fig. 3, B and
C).
Proprotein Convertases Cleave Human Peroxidasin at Arg1336 —Analysis of the hPxdn protein sequence directly after
the predicted PC recognition site suggests that the sequence of
the proteolytically cleaved fragment (hPxdn-PCF) will begin
with SLEFSYQ (Fig. 4A). To confirm the predicted site for PC
processing of Pxdn and the sequence of the resulting hPxdnPCF, the C-terminal 30-kDa fragment was submitted for N-terminal sequencing. Edman sequencing revealed the sequence
immediately after Arg-1336 at the C-terminal end of the RGRR
predicted PC site (Fig. 4B). To further confirm this site, the
RGRR sequence was mutated to RGAA, which would not be
amenable to PC processing. As predicted, the RGAA mutant of
hPxdn (hPxdn-RGAA) was not cleaved and did not produce the
30-kDa C-terminal fragment (Fig. 4C).
Proprotein Convertase Processing Enhances Pxdn Activity—
PC processing of catalytic proteins often activates or enhances
the activity of the target protein. To investigate whether PC
processing of Pxdn affects catalytic activity, recombinantly
expressed wild type hPxdn and hPxdn-RGAA were purified.
Both proteins exhibited similar heme incorporation based on
A415/A280 ratios, but the RGAA mutant demonstrated reduced
peroxidase activity by tetramethylbenzidine (TMB) oxidation
and diminished HOBr production (Fig. 5). However, the biologic significance of Pxdn catalytic activity lies in the production of HOBr as a reactive intermediate to form sulfilimine
cross-links in the collagen IV network. Moreover, although
VOLUME 291 • NUMBER 46 • NOVEMBER 11, 2016
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FIGURE 2. Pxdn undergoes PC processing. A, proprotein convertase cleavage site prediction results for Pxdn using the ProP 1.0 server (14). B, immunoblot of
ammonium sulfate precipitated media under reducing conditions from HEK293 cells stably producing Pxdn that were either cultured without (⫺) or with (⫹)
100 M decanoyl-RVKR-chloromethyl ketone (Dec-RVKR-CMK) proprotein convertase inhibitor. C, immunoblot of ammonium sulfate-precipitated media under
reducing conditions from HEK293T cells transiently transfected with vector only (Mock), Pxdn, the PC inhibitor ␣1-antitrypsin Portland variant (PDX), or
co-transfected with Pxdn and PDX (Pxdn ⫹ PDX). D, immunoblot of cell lysate and ammonium sulfate-precipitated media under reducing conditions from
HEK293 cells stably expressing Pxdn. Blots were probed with anti-V5 antibody and are representative of three independent experiments.

diminished without PC processing, residual catalytic activity
could sufficiently cross-link collagen IV. Using CRISPR-Cas9
gene editing, the Pxdn gene was abrogated in the endodermal
PFHR9 cell line, a previously characterized system that produces large quantities of cross-linked collagen IV and basement
membrane. As expected, in the absence of Pxdn, the collagen IV
network was devoid of sulfilimine cross-links. Pxdn was then
reintroduced into these knock-out cells either as wild type
hPxdn or as hPxdn-RGAA. The number of sulfilimine crosslinks per hexamer was diminished in the RGAA mutant compared with wild type hPxdn (Fig. 6, A and B). These data suggested that PC processing of Pxdn is physiologically required
for efficient sulfilimine bond formation. However, to further
confirm that unprocessed Pxdn, even at high levels, is functionally deficient, we utilized the “overlay assay” where stably transfected cells overexpressing wild type or the mutant hPxdnRGAA were plated on top of an uncross-linked collagen IV
matrix from PFHR9 cells. Despite overexpression, the mutant
hPxdn-RGAA protein remained less efficient at forming sulfilimine cross-links in collagen IV (Fig. 6, C and D). Taken
NOVEMBER 11, 2016 • VOLUME 291 • NUMBER 46

together, these data suggest that PC processing of hPxdn
enhances enzymatic and functional activity.

Discussion
In this work we found that PCs proteolytically process peroxidasin near its C terminus, thereby releasing a large, catalytically active fragment and a smaller fragment consisting primarily of the C-terminal vWFC domain. This processing of
Pxdn enhances catalytic activity and promotes the formation of
sulfilimine cross-links in the collagen IV network of BM. Thus,
PC processing of Pxdn represents a key regulatory step in
the biosynthesis and function of Pxdn to support BM and tissue
integrity. Expectedly, the peroxidasin-collagen IV-sulfilimine
bond triad is conserved throughout the animal kingdom, where
the evolution of basement membranes is thought to be a key
step in the development of multicellular tissues. The multidomain structure of peroxidasin is mostly conserved in Bilateria,
whereas there is a distinct lack of the C-terminal vWFC domain
in Cnidaria (11). Interestingly, we find that a PC cleavage site
between the catalytic and vWFC domains is predicted in nearly
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. The C-terminal fragment of peroxidasin (Pxdn-PCF) released by proprotein convertase processing is a non-covalently linked oligomer. A,
immunoblot of ammonium sulfate-precipitated media from HEK293 cells stably transfected with hPxdn. The migration of the proteolytically processed
C-terminal fragment is unchanged with the addition of 50 mM dithiothreitol (DTT; arrow). Blots were probed with anti-V5 antibody. B, gel filtration chromatography elution profile based on absorbance at 280 nm (mAU) of proteolytically processed C-terminal fragment of Pxdn (Pxdn-PCF; solid line) and molecular
mass standards (dashed line) run successively on GE S200 gel filtration column (GE Healthcare). C, estimation of molecular weight of PXDN-PCF using gel
filtration chromatography retention volume of molecular weight standards (black) and PXDN-PCF (red).

all Bilateria, adding further credence to the importance of this
processing in regulation of Pxdn function (Fig. 7). Because Pxdn
produces a powerful, potentially damaging oxidant in the form
of HOBr, the processing of Pxdn extracellularly may activate its
catalytic activity to act upon its collagen IV substrate while
minimizing collateral oxidative damage.
Based on this and prior work, a model for Pxdn biosynthesis
may be proposed. Pxdn monomers may initially trimerize

24012 JOURNAL OF BIOLOGICAL CHEMISTRY

through the vWFC domain, which allows for cysteines
throughout the remainder of the molecule to approach one
another and form disulfide linkages to covalently consolidate
the homotrimeric state (7, 13, 16). The vWFC domain itself,
although cysteine-rich, remains a noncovalent trimer with
either free cysteines or cysteines forming intramolecular disulfide bridges. Temporally close to extracellular secretion, PCs
cleave Pxdn releasing the vWFC domain oligomer. This actiVOLUME 291 • NUMBER 46 • NOVEMBER 11, 2016
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FIGURE 4. Proprotein convertases cleave peroxidasin at Arg-1336. A, schematic representation of the predicted Pxdn fragments that result upon proprotein convertase proteolytic processing. B, N-terminal Edman degradation sequencing cycles of the C-terminal fragment of Pxdn released after PC processing
(Alphalyse Inc., Palo Alto, CA). C, immunoblot of ammonium sulfate-precipitated media under reducing conditions from HEK293 cells transiently transfected
with hPxdn or hPxdn-RGAA and probed with anti-V5 antibody. Shown is a blot representative of three independent experiments.

FIGURE 5. Proprotein convertase proteolysis of peroxidasin enhances enzymatic activity. A, ratio of absorbance at 415 nm and 280 nm for both Pxdn and
Pxdn-RGAA demonstrating equal heme incorporation. B, peroxidase activity as determined by TMB oxidation measured as absorbance at 650 nm (A650). C,
HOBr production expressed as nmol of HOBr generated/nmol of enzyme/min measured in 1⫻ PBS supplemented with 100 M NaBr for wild type hPxdn (WT)
and mutant hPxdn-RGAA (RGAA). In all panels individual data points are displayed with mean (dotted line) and S.D. Data were analyzed using t test or analysis
of variance followed by post hoc pairwise comparisons with Bonferroni’s correction for multiple comparisons (**, p ⱕ 0.01 compared with WT Pxdn).

vates the nearby catalytic domain to form HOBr as an intermediate to create sulfilimine cross-links in collagen IV. A caveat to
this model is that gel filtration chromatography of the released
C-terminal fragment containing the vWFC domain revealed an
oligomer of nearly five subunits rather than the expected three
subunits (Fig. 3C). This may reflect a larger hydrodynamic
radius such that the trimeric C-terminal fragment anomalously
elutes as a larger oligomer. Alternatively, the C-terminal vWFC
domain may be a dimer of two trimers or a hexamer that forms
either before or after proteolytic processing with a slightly
smaller than expected hydrodynamic radius. Lastly, after PC
processing, trimeric C-terminal fragments may dissociate and
reorganize into pentamers.
PC processing of secreted proteins is ubiquitously present in
nearly all mammalian tissues and, therefore, plays a critical role
in normal physiology and disease. In regard to extracellular
matrix homeostasis, PC processing activates several proteases,
such as matrix metalloproteases, and also promotes the polymerization of structural proteins (15, 16). Whereas most processing events occur on the N-terminal end of proteins, several
extracellular matrix proteins, such as fibrillin, collagen V, and
NOVEMBER 11, 2016 • VOLUME 291 • NUMBER 46

now peroxidasin, undergo C-terminal processing (19, 20).
Besides Pxdn, PCs also cleave other animal heme peroxidases,
such as MPO and TPO. Unlike Pxdn, PC processing of MPO
and TPO targets the N terminus and primarily affects protein
trafficking rather than catalytic activity (21, 22).
Taken together, our work begins to shed light on the regulation of Pxdn function and identifies PC processing as an activation step to target HOBr efficiently toward collagen IV and
minimize oxidative damage. Future mechanistic work will
focus on the molecular mechanism of this regulation, which
may involve the vWFC domain of Pxdn acting as a negative
regulator of its catalytic domain.

Experimental Procedures
Site-directed Mutagenesis—Full-length human peroxidasin
was used as the starting construct (23). The PC recognition
sequence within Pxdn, RGRR, was mutated to RGAA using
QuikChange mutagenesis as previously described (24).
Cell Culture—Human embryonic kidney 293 and 293T cells
(American Type Culture Collection, Manassas, VA) were
grown in Dulbecco’s modified Eagle’s medium/F-12 medium
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 6. Proprotein convertase processing of peroxidasin enhances the
formation of sulfilimine cross-links in collagen IV. A and B, CRISPR generated Pxdn knock out PFHR-9 cells (Control) were rescued by stable transfection of either wild type (WT) or the mutant hPxdn-RGAA (RGAA). The matrix
containing collagen IV network was isolated 5 days post confluency. The
number of cross-links per collagen IV NC1 hexamer was determined using
densitometric quantitation of the dimeric and monomeric subunits from
SDS-PAGE of the collagenase-digested matrix. C and D, untransfected
HEK293 cells or HEK 293 cells stably transfected with either wild type (WT) or
the mutant hPxdn-RGAA (RGAA) were plated on PFHR-9 uncross-linked
matrix, and the underlying matrix was isolated 24 h after overlay for analysis
of collagen IV sulfilimine cross-link content. The number of cross-links per
collagen IV NC1 hexamer was determined using densitometric quantitation
of the dimeric and monomeric subunits from SDS-PAGE of the collagenasedigested matrix. In all panels individual data points are displayed with mean
(dotted line) and S.D. Data were analyzed using analysis of variance followed
by post hoc pairwise comparisons with Bonferroni’s correction for multiple
comparisons (*, p ⱕ 0.05; **, p ⱕ 0.01 compared with WT Pxdn).

(Sigma) containing 5% fetal bovine serum. Stable transfections
were done by using the calcium phosphate precipitation
method and 6 g of plasmid DNA with both the native hPxdn
and mutant hPxdn-RGAA construct. Clones resistant to 250
g/ml G418 (Mediatech, Manassas, VA) were isolated and
expanded. Stably transfected clones were screened for protein
expression from serum-free medium by Western blotting using
anti-V5 antibody (Life Technologies). Transient transfections
were done using Lipofectamine LTX reagent and 2.5 g of plasmid DNA following the manufacturer’s protocol (Life Technologies). The medium was collected 24 h post transfection and
analyzed by anti-V5 immunoblotting.
Protein Purification—Recombinant hPxdn was purified as
previously described (4). Recombinant hPxdn-RGAA and
hPxdn-PCF proteins were purified from conditioned media
collected from stably transfected HEK293 cells by affinity chromatography on a HiTrap TALON affinity column on an
ÄKTApurifier HPLC system (GE Healthcare) according to the
manufacturer’s instructions and eluted with 100 mM imidazole.
The resulting peak fractions were combined, then precipitated
with 40% ammonium sulfate and reconstituted in cetyltrimethylammonium bromide (CTAB) buffer (150 mM NaCl, 50 mM
Tris-Cl, pH 7.5, 0.2% CTAB) with protease inhibitors (0.5 mM
phenylmethylsulfonyl fluoride, 10 g/ml of leupeptin, and 1
g/ml of pepstatin). The concentration of purified protein was
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determined using the bicinchoninic acid (BCA) assay (ThermoFisher Scientific Pierce).
Gel Electrophoresis and Western Blotting—Purified proteins
and cell culture medium were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using
4 –20% gradient gels (Bio-Rad) then transferred to nitrocellulose membranes, blocked with 5% nonfat milk in 1⫻ TBS with
0.05% Tween 20 for 1 h, and probed overnight with anti-V5
antibody (Life Technologies) at 1:5000 dilution. Bound antibody was detected using anti-mouse secondary antibodies
conjugated with alkaline phosphatase or horseradish peroxidase followed by detection with colorimetric or luminescent
substrates.
Determination of Relative Heme Incorporation—To determine the relative incorporation of heme for each construct,
UV-visible spectrums of both wild type hPxdn and the mutant
hPxdn-RGAA were read, and the ratio of the peak absorbance
at 415 nm and 280 nm was calculated.
Peroxidase Activity Assays—Purified hPxdn and mutant
hPxdn-RGAA concentrations were determined using BCA
protein assay, equal amounts of protein were added to a 96-well
microtiter plate in triplicate along with TMB liquid substrate
(Sigma), and the absorbance was read at 650 nm (A650) using a
SpectraMax 190 plate reader (Molecular Devices LLC, Sunnyvale, CA).
Measurement of Hypobromous Acid Production—Hypobromous acid (HOBr) production was determined as previously
described (4). Briefly, hypobromous acid standard solutions
were freshly prepared by combining 80 mM NaOCl with 90 mM
KBr and adjusting the pH to 7.4 after 1 min. The HOBr concentration was quantified using A329 ⫽ 332 M⫺1cm⫺1 at alkaline
pH. Equimolar amounts of hPxdn and hPxdn-RGAA were
combined with 5 mM taurine in 1⫻ PBS ⫹ 100 M NaBr, and
reactions were initiated with the addition of 50 M H2O2, and
allowed to proceed for 10 min. Reactions were stopped with the
addition of 20 g/ml bovine liver catalase (Sigma). After 5–10
min, 1⁄4 volume of developing buffer (0.4 M sodium acetate, pH
5.4, 2 mM tetramethylbenzidine, 10% dimethylformamide) was
added, and A650 was measured. HOBr standards were used to
calculate concentrations from A650 measurements.
Stably Transfected Cell Overlay Assay for Cross-link Determination—PFHR-9 cells were cultured as previously described
(10). Briefly, cells were grown at 10% CO2 for 5 days post-confluency in the presence of 50 M phloroglucinol to inhibit peroxidasin-mediated sulfilimine bond formation (4). The PFHR-9
cells were then removed using two detergent extractions with
hypotonic buffer (10 mM Tris-Cl, pH 7.5, ⫹ 0.1 mM CaCl2 ⫹
0.1% bovine serum albumin) ⫹ 1% Triton-X, followed by 2
washes with hypotonic buffer ⫹ 0.1% sodium deoxycholate.
The remaining matrix was extracted with 4 M guanidine hydrochloride ⫹ 50 mM Tris-Cl, pH 7.5, and then washed extensively
with 1⫻ PBS. These PFHR-9 matrix plates were either stored
under sterile conditions at ⫺80 °C or used immediately.
HEK293 cells stably transfected with either wild type hPxdn
or hPxdn-RGAA mutant construct were plated onto PFHR-9
matrix and were then incubated for 24 h in the presence of 5 M
hematin and 5 mM sodium butyrate. After incubation, the cells
and underlying ECM were scraped into deoxycholate buffer
VOLUME 291 • NUMBER 46 • NOVEMBER 11, 2016
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FIGURE 7. The presence of a C-terminal proprotein convertase recognition sequence in peroxidasin is evolutionarily conserved. Shown is a schematic
representation of peroxidasin among differing species. The presence of a predicted PC recognition sequence is found across several Eumetazoa phyla.
Sequence data were gathered from National Center for Biotechnology Information Reference Sequence. PC recognition site scores were predicted by the ProP
1.0 server (14).

(1% sodium deoxycholate, 10 mM Tris-Cl, pH 7.5, and 1 mM
EDTA-Na) including protease inhibitors (0.5 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, and 1 g/ml pepstatin)
and sonicated to eliminate viscosity. The resulting supernatant
was designated as the cell lysate, and the insoluble pellet was
further processed to isolate ECM. To determine sulfilimine
cross-link content of collagen IV, the ECM fraction was
digested with collagenase (50 g/ml; CLSPA grade, Worthington Biochemical Corp., Lakewood, NJ) overnight at 37 °C in
collagenase buffer (100 mM NaCl, 50 mM Tris-Cl, pH 7.5, 25 mM
6-aminocaproic acid, 5 mM benzamidine, 0.5 mM PMSF, and 50
M phloroglucinol). The collagenase digest supernatant underwent SDS-PAGE under non-reducing conditions followed by
Coomassie Blue staining to visualize and quantify sulfilimine
cross-linked dimeric and non-cross-linked monomeric subunits. The average number of cross-links per hexamer was
determined using the density of the single (D1)- and doublecross-linked (D2) and non-cross-linked (M) subunit bands:
cross-links per hexamer ⫽ (6 ⫻ fraction D2) ⫹ (3 ⫺ fraction
D1).
CRISPR-mediated Knock-out—PFHR9 cells were transfected
with guide RNAs targeting the first exon of the mouse Pxdn
gene and a hygromycin resistance homologous recombination
vector using Lipofectamine 2000 transfection reagent and a
total of 3 g of DNA per the manufacturer’s protocol (Life
Technologies). Transfected cells underwent selection with 250
g/ml hygromycin B and 0.2 M fialuridine 48 h after transfection. Resistant clones were isolated, expanded, and screened for
the presence and/or absence of the knock-out cassette via homologous recombination utilizing the primers Pxdn HR forNOVEMBER 11, 2016 • VOLUME 291 • NUMBER 46

ward primer (5⬘-GGGGGCTGTCCCTAGATCTAT-3⬘) and
HR reverse primer (5⬘-AAGGCGCAAAGCACAACTCCA-3⬘).
The clones were also screened for the presence and/or absence
of the wild type allele utilizing the primers Pxdn WT forward
primer (5⬘-CTCCTCCGCTGCTGTTCACGC-3⬘) and WT
reverse primer (5⬘-AATCGCACGTCCCGCAGACCC-3⬘).
Author Contributions—G. B. conceived the project. S. C. conducted
most of the experiments, and G. B. conducted the preliminary work.
Both S. C. and G. B. wrote the manuscript.
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